Loading…

Ketone metabolism in the failing heart

The high energy demands of the heart are met primarily by the mitochondrial oxidation of fatty acids and glucose. However, in heart failure there is a decrease in cardiac mitochondrial oxidative metabolism and glucose oxidation that can lead to an energy starved heart. Ketone bodies are readily oxid...

Full description

Saved in:
Bibliographic Details
Published in:Biochimica et biophysica acta. Molecular and cell biology of lipids 2020-12, Vol.1865 (12), p.158813-158813, Article 158813
Main Authors: Lopaschuk, Gary D., Karwi, Qutuba G., Ho, Kim L., Pherwani, Simran, Ketema, Ezra B.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c362t-2fb677c500cc898d6c36a945a269f07403fe33900ea19bdd76835c10a59bea643
cites cdi_FETCH-LOGICAL-c362t-2fb677c500cc898d6c36a945a269f07403fe33900ea19bdd76835c10a59bea643
container_end_page 158813
container_issue 12
container_start_page 158813
container_title Biochimica et biophysica acta. Molecular and cell biology of lipids
container_volume 1865
creator Lopaschuk, Gary D.
Karwi, Qutuba G.
Ho, Kim L.
Pherwani, Simran
Ketema, Ezra B.
description The high energy demands of the heart are met primarily by the mitochondrial oxidation of fatty acids and glucose. However, in heart failure there is a decrease in cardiac mitochondrial oxidative metabolism and glucose oxidation that can lead to an energy starved heart. Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart. Ketone oxidation is increased in the failing heart, which may be an adaptive response to lessen the severity of heart failure. While ketone have been widely touted as a “thrifty fuel”, increasing ketone oxidation in the heart does not increase cardiac efficiency (cardiac work/oxygen consumed), but rather does provide an additional fuel source for the failing heart. Increasing ketone supply to the heart and increasing mitochondrial ketone oxidation increases mitochondrial tricarboxylic acid cycle activity. In support of this, increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients. Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart. While ketogenic diets increase circulating ketone levels, minimal benefit on cardiac function in heart failure has been observed, possibly due to the fact that these dietary regimens also markedly increase circulating fatty acids. Recent studies, however, have suggested that administration of ketone ester cocktails may improve cardiac function in heart failure. Combined, emerging data suggests that increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure. •Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart.•Increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients.•Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart.•Ketone ester cocktails may improve cardiac function in heart failure.•Increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure.
doi_str_mv 10.1016/j.bbalip.2020.158813
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2442598180</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1388198120302055</els_id><sourcerecordid>2442598180</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-2fb677c500cc898d6c36a945a269f07403fe33900ea19bdd76835c10a59bea643</originalsourceid><addsrcrecordid>eNp9kEtLBDEQhIMoPlb_gcicxMusnWSSSS6CLL5wwYueQybT42aZx5rMCv57s4x69NRNUdVNfYScU5hToPJ6Pa8q2_rNnAFLklCK8j1yTFWpcyap2k87VyqnWtEjchLjGoAKzsUhOeJMM6BcH5PLZxyHHrMOR1sNrY9d5vtsXGHWWN_6_j1boQ3jKTlobBvx7GfOyNv93eviMV--PDwtbpe545KNOWsqWZZOADintKplkq0uhGVSN1AWwBvkXAOgpbqq61IqLhwFK3SFVhZ8Rq6mu5swfGwxjqbz0WHb2h6HbTSsKJhIhRQkazFZXRhiDNiYTfCdDV-GgtkRMmszETI7QmYilGIXPx-2VYf1X-gXSTLcTAZMPT89BhOdx95h7QO60dSD___DN-lQdnc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2442598180</pqid></control><display><type>article</type><title>Ketone metabolism in the failing heart</title><source>ScienceDirect Journals</source><creator>Lopaschuk, Gary D. ; Karwi, Qutuba G. ; Ho, Kim L. ; Pherwani, Simran ; Ketema, Ezra B.</creator><creatorcontrib>Lopaschuk, Gary D. ; Karwi, Qutuba G. ; Ho, Kim L. ; Pherwani, Simran ; Ketema, Ezra B.</creatorcontrib><description>The high energy demands of the heart are met primarily by the mitochondrial oxidation of fatty acids and glucose. However, in heart failure there is a decrease in cardiac mitochondrial oxidative metabolism and glucose oxidation that can lead to an energy starved heart. Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart. Ketone oxidation is increased in the failing heart, which may be an adaptive response to lessen the severity of heart failure. While ketone have been widely touted as a “thrifty fuel”, increasing ketone oxidation in the heart does not increase cardiac efficiency (cardiac work/oxygen consumed), but rather does provide an additional fuel source for the failing heart. Increasing ketone supply to the heart and increasing mitochondrial ketone oxidation increases mitochondrial tricarboxylic acid cycle activity. In support of this, increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients. Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart. While ketogenic diets increase circulating ketone levels, minimal benefit on cardiac function in heart failure has been observed, possibly due to the fact that these dietary regimens also markedly increase circulating fatty acids. Recent studies, however, have suggested that administration of ketone ester cocktails may improve cardiac function in heart failure. Combined, emerging data suggests that increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure. •Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart.•Increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients.•Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart.•Ketone ester cocktails may improve cardiac function in heart failure.•Increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure.</description><identifier>ISSN: 1388-1981</identifier><identifier>EISSN: 1879-2618</identifier><identifier>DOI: 10.1016/j.bbalip.2020.158813</identifier><identifier>PMID: 32920139</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Drug Discovery ; Energy Metabolism - drug effects ; Fatty acid oxidation ; Glucose - metabolism ; Glucose oxidation ; Heart - drug effects ; Heart - physiopathology ; Heart failure ; Heart Failure - drug therapy ; Heart Failure - metabolism ; Heart Failure - physiopathology ; Humans ; Ketone Bodies - metabolism ; Ketone body ; NLRP3 inflammasome ; Oxidation-Reduction - drug effects ; Sodium glucose co-transporter 2 inhibitors</subject><ispartof>Biochimica et biophysica acta. Molecular and cell biology of lipids, 2020-12, Vol.1865 (12), p.158813-158813, Article 158813</ispartof><rights>2020 Elsevier B.V.</rights><rights>Copyright © 2020 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-2fb677c500cc898d6c36a945a269f07403fe33900ea19bdd76835c10a59bea643</citedby><cites>FETCH-LOGICAL-c362t-2fb677c500cc898d6c36a945a269f07403fe33900ea19bdd76835c10a59bea643</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32920139$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lopaschuk, Gary D.</creatorcontrib><creatorcontrib>Karwi, Qutuba G.</creatorcontrib><creatorcontrib>Ho, Kim L.</creatorcontrib><creatorcontrib>Pherwani, Simran</creatorcontrib><creatorcontrib>Ketema, Ezra B.</creatorcontrib><title>Ketone metabolism in the failing heart</title><title>Biochimica et biophysica acta. Molecular and cell biology of lipids</title><addtitle>Biochim Biophys Acta Mol Cell Biol Lipids</addtitle><description>The high energy demands of the heart are met primarily by the mitochondrial oxidation of fatty acids and glucose. However, in heart failure there is a decrease in cardiac mitochondrial oxidative metabolism and glucose oxidation that can lead to an energy starved heart. Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart. Ketone oxidation is increased in the failing heart, which may be an adaptive response to lessen the severity of heart failure. While ketone have been widely touted as a “thrifty fuel”, increasing ketone oxidation in the heart does not increase cardiac efficiency (cardiac work/oxygen consumed), but rather does provide an additional fuel source for the failing heart. Increasing ketone supply to the heart and increasing mitochondrial ketone oxidation increases mitochondrial tricarboxylic acid cycle activity. In support of this, increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients. Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart. While ketogenic diets increase circulating ketone levels, minimal benefit on cardiac function in heart failure has been observed, possibly due to the fact that these dietary regimens also markedly increase circulating fatty acids. Recent studies, however, have suggested that administration of ketone ester cocktails may improve cardiac function in heart failure. Combined, emerging data suggests that increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure. •Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart.•Increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients.•Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart.•Ketone ester cocktails may improve cardiac function in heart failure.•Increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure.</description><subject>Animals</subject><subject>Drug Discovery</subject><subject>Energy Metabolism - drug effects</subject><subject>Fatty acid oxidation</subject><subject>Glucose - metabolism</subject><subject>Glucose oxidation</subject><subject>Heart - drug effects</subject><subject>Heart - physiopathology</subject><subject>Heart failure</subject><subject>Heart Failure - drug therapy</subject><subject>Heart Failure - metabolism</subject><subject>Heart Failure - physiopathology</subject><subject>Humans</subject><subject>Ketone Bodies - metabolism</subject><subject>Ketone body</subject><subject>NLRP3 inflammasome</subject><subject>Oxidation-Reduction - drug effects</subject><subject>Sodium glucose co-transporter 2 inhibitors</subject><issn>1388-1981</issn><issn>1879-2618</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLBDEQhIMoPlb_gcicxMusnWSSSS6CLL5wwYueQybT42aZx5rMCv57s4x69NRNUdVNfYScU5hToPJ6Pa8q2_rNnAFLklCK8j1yTFWpcyap2k87VyqnWtEjchLjGoAKzsUhOeJMM6BcH5PLZxyHHrMOR1sNrY9d5vtsXGHWWN_6_j1boQ3jKTlobBvx7GfOyNv93eviMV--PDwtbpe545KNOWsqWZZOADintKplkq0uhGVSN1AWwBvkXAOgpbqq61IqLhwFK3SFVhZ8Rq6mu5swfGwxjqbz0WHb2h6HbTSsKJhIhRQkazFZXRhiDNiYTfCdDV-GgtkRMmszETI7QmYilGIXPx-2VYf1X-gXSTLcTAZMPT89BhOdx95h7QO60dSD___DN-lQdnc</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Lopaschuk, Gary D.</creator><creator>Karwi, Qutuba G.</creator><creator>Ho, Kim L.</creator><creator>Pherwani, Simran</creator><creator>Ketema, Ezra B.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202012</creationdate><title>Ketone metabolism in the failing heart</title><author>Lopaschuk, Gary D. ; Karwi, Qutuba G. ; Ho, Kim L. ; Pherwani, Simran ; Ketema, Ezra B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-2fb677c500cc898d6c36a945a269f07403fe33900ea19bdd76835c10a59bea643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Drug Discovery</topic><topic>Energy Metabolism - drug effects</topic><topic>Fatty acid oxidation</topic><topic>Glucose - metabolism</topic><topic>Glucose oxidation</topic><topic>Heart - drug effects</topic><topic>Heart - physiopathology</topic><topic>Heart failure</topic><topic>Heart Failure - drug therapy</topic><topic>Heart Failure - metabolism</topic><topic>Heart Failure - physiopathology</topic><topic>Humans</topic><topic>Ketone Bodies - metabolism</topic><topic>Ketone body</topic><topic>NLRP3 inflammasome</topic><topic>Oxidation-Reduction - drug effects</topic><topic>Sodium glucose co-transporter 2 inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lopaschuk, Gary D.</creatorcontrib><creatorcontrib>Karwi, Qutuba G.</creatorcontrib><creatorcontrib>Ho, Kim L.</creatorcontrib><creatorcontrib>Pherwani, Simran</creatorcontrib><creatorcontrib>Ketema, Ezra B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochimica et biophysica acta. Molecular and cell biology of lipids</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lopaschuk, Gary D.</au><au>Karwi, Qutuba G.</au><au>Ho, Kim L.</au><au>Pherwani, Simran</au><au>Ketema, Ezra B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ketone metabolism in the failing heart</atitle><jtitle>Biochimica et biophysica acta. Molecular and cell biology of lipids</jtitle><addtitle>Biochim Biophys Acta Mol Cell Biol Lipids</addtitle><date>2020-12</date><risdate>2020</risdate><volume>1865</volume><issue>12</issue><spage>158813</spage><epage>158813</epage><pages>158813-158813</pages><artnum>158813</artnum><issn>1388-1981</issn><eissn>1879-2618</eissn><abstract>The high energy demands of the heart are met primarily by the mitochondrial oxidation of fatty acids and glucose. However, in heart failure there is a decrease in cardiac mitochondrial oxidative metabolism and glucose oxidation that can lead to an energy starved heart. Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart. Ketone oxidation is increased in the failing heart, which may be an adaptive response to lessen the severity of heart failure. While ketone have been widely touted as a “thrifty fuel”, increasing ketone oxidation in the heart does not increase cardiac efficiency (cardiac work/oxygen consumed), but rather does provide an additional fuel source for the failing heart. Increasing ketone supply to the heart and increasing mitochondrial ketone oxidation increases mitochondrial tricarboxylic acid cycle activity. In support of this, increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients. Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart. While ketogenic diets increase circulating ketone levels, minimal benefit on cardiac function in heart failure has been observed, possibly due to the fact that these dietary regimens also markedly increase circulating fatty acids. Recent studies, however, have suggested that administration of ketone ester cocktails may improve cardiac function in heart failure. Combined, emerging data suggests that increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure. •Ketone bodies are readily oxidized by the heart, and can provide an additional source of energy for the failing heart.•Increasing circulating ketone by iv infusion of ketone bodies acutely improves heart function in heart failure patients.•Chronically, treatment with sodium glucose co-transporter 2 inhibitors, which decreases the severity of heart failure, also increases ketone body supply to the heart.•Ketone ester cocktails may improve cardiac function in heart failure.•Increasing cardiac ketone oxidation may be a therapeutic strategy to treat heart failure.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>32920139</pmid><doi>10.1016/j.bbalip.2020.158813</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1388-1981
ispartof Biochimica et biophysica acta. Molecular and cell biology of lipids, 2020-12, Vol.1865 (12), p.158813-158813, Article 158813
issn 1388-1981
1879-2618
language eng
recordid cdi_proquest_miscellaneous_2442598180
source ScienceDirect Journals
subjects Animals
Drug Discovery
Energy Metabolism - drug effects
Fatty acid oxidation
Glucose - metabolism
Glucose oxidation
Heart - drug effects
Heart - physiopathology
Heart failure
Heart Failure - drug therapy
Heart Failure - metabolism
Heart Failure - physiopathology
Humans
Ketone Bodies - metabolism
Ketone body
NLRP3 inflammasome
Oxidation-Reduction - drug effects
Sodium glucose co-transporter 2 inhibitors
title Ketone metabolism in the failing heart
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T08%3A55%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ketone%20metabolism%20in%20the%20failing%20heart&rft.jtitle=Biochimica%20et%20biophysica%20acta.%20Molecular%20and%20cell%20biology%20of%20lipids&rft.au=Lopaschuk,%20Gary%20D.&rft.date=2020-12&rft.volume=1865&rft.issue=12&rft.spage=158813&rft.epage=158813&rft.pages=158813-158813&rft.artnum=158813&rft.issn=1388-1981&rft.eissn=1879-2618&rft_id=info:doi/10.1016/j.bbalip.2020.158813&rft_dat=%3Cproquest_cross%3E2442598180%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c362t-2fb677c500cc898d6c36a945a269f07403fe33900ea19bdd76835c10a59bea643%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2442598180&rft_id=info:pmid/32920139&rfr_iscdi=true